Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 9.09
Key Takeaways
Risk factor
Fair trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Good margins and returns
Data is available to registered users only
Data is available to registered users only
About
Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers APIs, liquid crystal compounds, and intermediates. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV
Data is available to registered users only
Target Price
The average target price of 300636.SZ is 8.7 and suggests 4% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to
Data is available to registered users only
